NYSE:SCL Key Ratios
| Market Cap $ M | 1,389.19 |
| Enterprise Value $ M | 1,967.86 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 29.24 |
| Forward PE Ratio | 17.26 |
| Price/Book | 1.15 |
| Price/Sales | 0.56 |
| Price/Free Cash Flow | 38.21 |
| Price/Owner Earnings | -- |
| Payout Ratio % | 0.75 |
| Revenue (TTM) $ M | 2,432.00 |
| EPS (TTM) $ | -0.12 |
| Beneish M-Score | -2.57 |
| 10-y EBITDA Growth Rate % | 0.20 |
| 5-y EBITDA Growth Rate % | -6.80 |
| y-y EBITDA Growth Rate % | 11.20 |
| EV-to-EBIT | 20.08 |
| EV-to-EBITDA | 8.66 |
| PEG | -- |
| Shares Outstanding M | 22.73 |
| Net Margin (%) | -0.11 |
| Operating Margin % | 3.34 |
| Pre-tax Margin (%) | -0.02 |
| Quick Ratio | 0.77 |
| Current Ratio | 1.15 |
| ROA % (ttm) | -0.11 |
| ROE % (ttm) | -0.22 |
| ROIC % (ttm) | 4.37 |
| Dividend Yield % | 2.57 |
| Altman Z-Score | 2.55 |
SCL Number of Guru Trades
SCL Volume of Guru Trades
Gurus Latest Trades with NYSE:SCL
NYSE:SCL is held by these investors
Stepan Co Insider Transactions
Guru Commentaries on NYSE:SCL
Stepan Company (SCL) was a detractor in the Small Cap strategy in the third quarter. The company continues to execute on its strategy to grow its functional surfactants, which serve the agriculture and oilfield market, as well as its Tier 2 and Tier 3 surfactant volumes. However, weakness in the commodity consumer product end markets offset growth in these areas, and overall Surfactant segment volumes were down 1%. In the Polymer segment, volumes were up 7% driven by strength in the North American and European rigid polyols end markets despite continued headwinds from a weak macro environment and tariff uncertainty. We expect this ratio to come down now that the heavy investment period is behind them.
News about NYSE:SCL
Total 0- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
